Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2024; 49(4): 988-991


Whole Stevia leaf powder or Rebaudioside A; Effects of supplementation on obesity induced oxidative stress

Amna Faruqi, Sadia Mubarak, Sikander Subuctageen, Tooba Zafar, Saima Latif Qureishi, Asma Irfan.




Abstract

Objective: To determine and compare the effect of diet supplementation with dry, powdered Stevia leaf and its highly purified Rebaudioside A glycoside, on obesity induced oxidative stress in a murine model.
Methodology: This experimental study included 120 Sprague Dawley male rats divided in four groups with 30 animals in each group. Normal control (Group 1, n=30), was fed an ordinary diet. Ninety rats were made obese by administration of a high fat diet (HFD) for eight weeks and after confirmation of obesity, using Lee Index, were randomly allocated to group 2 (Obese control), group 3 (obese+Stevia) and group 4 (Obese+Rebaudioside A). HFD was continued for a further six weeks along with supplementation with Stevia leaf powder (group 3) and Rebaudioside A (group 4). Oxidative stress was determined by testing testicular tissue supernatant for Malondialdehyde (MDA) and Catalase (CAT) activity using animal kits.
Results: Obesity caused a significant increase in tissue levels of MDA (p

Key words: Oxidative stress, antioxidant, obesity, nutraceutical, stevia, Rebaudioside A.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.